Companies · Healthtech

Hinge Health, Inc.

SAN FRANCISCO · Healthtech · refined from filed group “Other Technology · https://www.hingehealth.com/

Diligence memoA one-page analyst read on Hinge Health, Inc. — recommendation, valuation, rhythm, risks.
$862.5M
Total raised · real
9
Rounds
41.7×
Latest step-up
Top 1%
Sector rank · raised
Series D+
Latest stage · inferred · Fri Oct 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

Hinge Health, Inc. looks over-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the healthtech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Over-valued
  • Modeled value is 2.76× the median modeled value of Series D+ Healthtech companies in 2019–2021 (11 peers) — value vs value, same stage and era.
Dormant
  • Last raise 4.7 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Healthtech

Hinge Health, Inc. is one of 2138 Healthtech companies tracked from SAN FRANCISCO. By capital raised it ranks among the largest (ahead of 100% of sector peers), and among the largest by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

AI analyst read est. — model-extracted from this company's public description, not a verified fact. 30%

operates a technology-led product inferred from public copy

Grounded in: “You are a venture analyst

The #1 clinic for joint & muscle pain. Join today and take control of your pain with access to our personalized virtual physical therapy program

The #1 clinic for joint & muscle pain. Join today and take control of your pain with access to our personalized virtual physical therapy program Get back to the things you love with access to virtual physical therapy, a dedicated care team, and more.

Find hingehealth online

Trades publicly as hingehealth.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
2
Investors (latest)
2021-10-22
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$2.5B$5.0B$7.5B$10.0BSeed · 2016-04-22 Raised $1.3M (real) Modeled valuation $37M (est)Seed2016Seed · 2016-04-22 Raised $1.1M (real) Modeled valuation $29M (est)Seed2016Seed · 2017-04-14 Raised $500K (real) Modeled valuation $14M (est)Seed2017Series A · 2017-07-07 Raised $9.6M (real) Modeled valuation $216M (est)Series A2017Series B · 2018-07-03 Raised $26M (real) Modeled valuation $644M (est)Series B2018Series B · 2019-05-21 Raised $15M (real) Modeled valuation $372M (est)Series B2019Series C · 2020-01-10 Raised $92M (real) Modeled valuation $2.3B (est)Series C2020Series D+ · 2020-12-21 Raised $309M (real) Modeled valuation $7.2B (est)Series D+2020Series D+ · 2021-03-17 Raised $9.6M (real) Modeled valuation $211M (est)Series D+2021Series D+ · 2021-10-22 Raised $400M (real) Modeled valuation $7.7B (est)Series D+2021+$1.1M+$500K+$9.6M+$26M+$15M+$92M+$309M+$9.6M+$400MCumulative $864M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$1.3M · 2016
Seed extension$1.1M · 2016
Seed extension$500K · 2017
Series A$9.6M · 2017
Series B$26.0M · 2018
Series B extension$15.0M · 2019
Series C$91.5M · 2020
Series D+$309.0M · 2020
Series D+ extension$9.6M · 2021
Series D+ extension$400.0M · 2021

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 83%.

Modeled valuation trajectory
$7.7B
Base estimate est.
$2.1B
Conservative case
$14.5B
Upside case
$3.3B
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series D+a $100M–$400M round). Valuation is modeled from stage benchmarks scaled by the healthtech sector profile. Directional, not a quoted figure.

Seed · modeled $36.9M · 2016-04-222016Seed · modeled $29.3M · 2016-04-22Seed · modeled $13.9M · 2017-04-14Series A · modeled $216.1M · 2017-07-07Series B · modeled $644.4M · 2018-07-03Series B · modeled $371.8M · 2019-05-21Series C · modeled $2.3B · 2020-01-10Series D+ · modeled $7.2B · 2020-12-21Series D+ · modeled $210.5M · 2021-03-17Series D+ · modeled $7.7B · 2021-10-222021
Model inputs · modeled:benchmark-stage-stepup-v1
12%
Dilution assumption
Implied ownership sold in the financing.
80%
Survival probability
64% low · 88% high
1.25×/yr
Annual markup
1.40×/yr upside case
4.7 yr
Elapsed time used
4.7 yr actual, capped for stale marks
healthtech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
7 mo
Avg between rounds
$156.8M/yr
Capital velocity
10.2 yr
On record since
2016
First round
10
Rounds on file
How it compares to the market

Benchmarked against 2138 companies in Healthtech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 193× above median
This company$862.5M
Sector median$4.5M
Latest round — vs other Series D+ rounds in sector (real $, this stage) 3.5× above median
This company$400.0M
Sector median$115.5M
Modeled value — vs sector median (estimate, all stages) 227× above median
This company$7.7B
Sector median$33.8M

Raised more than 100% of sector peers (real $). Modeled value above 100% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series D+) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #1 of 11.

This companyCohort peer
$1.0B$10.0B$10.0M$100.0M$1.0B$10.0BCapital raised (log)Reify Health, Inc. · Series D+ Raised $220.3M · modeled $4.6B (est)Healthcare, Inc. · Series D+ Raised $246.8M · modeled $4.0B (est)Net Health Parent Holdings, L.P. · Series D+ Raised $160.6M · modeled $3.9B (est)Iora Health, Inc. · Series D+ Raised $364.9M · modeled $3.3B (est)Autonomous Medical Devices Inc · Series D+ Raised $142.4M · modeled $2.8B (est)Cue Health Inc. · Series D+ Raised $125.7M · modeled $2.6B (est)Mainstay Medical Holdings plc · Series D+ Raised $108.0M · modeled $2.4B (est)binx health Ltd · Series D+ Raised $103.6M · modeled $2.2B (est)HealthVerity, Inc. · Series D+ Raised $146.2M · modeled $2.1B (est)Swift Health Systems Inc. · Series D+ Raised $172.6M · modeled $2.0B (est)Hinge Health, Inc. (this company) Raised $862.5M · modeled $7.7B (est)Hinge Health, Inc.
CompanyStageRaised · realValue · estvs peer med.
Hinge Health, Inc. this companySeries D+$862.5M$7.7B2.76×
Reify Health, Inc.Series D+$220.3M$4.6B1.65×
Healthcare, Inc.Series D+$246.8M$4.0B1.45×
Net Health Parent Holdings, L.P.Series D+$160.6M$3.9B1.41×
Iora Health, Inc.Series D+$364.9M$3.3B1.17×
Autonomous Medical Devices IncSeries D+$142.4M$2.8B1.00×
Cue Health Inc.Series D+$125.7M$2.6B0.95×
Mainstay Medical Holdings plcSeries D+$108.0M$2.4B0.87×
binx health LtdSeries D+$103.6M$2.2B0.78×
HealthVerity, Inc.Series D+$146.2M$2.1B0.74×
Swift Health Systems Inc.Series D+$172.6M$2.0B0.73×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$1.3M2016-04-22$6.7M$36.9M85%
Seed$1.1M2016-04-22$5.3M$29.3M85%
Seed$500K2017-04-14$2.5M$13.9M90%
Series A$9.6M2017-07-07$43.5M$216.1M90%
Series B$26.0M2018-07-03$144.4M$644.4M90%
Series B$15.0M2019-05-21$83.3M$371.8M90%
Series C$91.5M2020-01-10$610.1M$2.3B90%
Series D+$309.0M2020-12-21$2.6B$7.2B90%
Series D+$9.6M2021-03-17$79.9M$210.5M90%
Series D+$400.0M2021-10-22$3.3B$7.7B90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$1.3M2016-04-22
    • First recorded raise — entered as Seed.
    • 4 investors on this round.
  2. Seed$1.1M2016-04-22
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 3 investors on this round.
  3. Seed$500K2017-04-14
    • Raised 12 mo later, in step with the ~14 mo sector norm.
    • Round 2.1× smaller than the prior — bridge or down round.
    • 4 investors on this round.
  4. Series A$9.6M2017-07-07
    • Came back fast: 3 mo vs the ~14 mo sector norm.
    • Round 19.1× larger than the prior — scaling up.
    • 7 investors on this round.
  5. Series B$26.0M2018-07-03
    • Raised 12 mo later, in step with the ~14 mo sector norm.
    • Round 2.7× larger than the prior — scaling up.
    • 7 investors on this round.
  6. Series B$15.0M2019-05-21
    • Raised 11 mo later, in step with the ~14 mo sector norm.
    • Round 1.7× smaller than the prior — bridge or down round.
    • 7 investors on this round.
  7. Series C$91.5M2020-01-10
    • Came back fast: 8 mo vs the ~14 mo sector norm.
    • Round 6.1× larger than the prior — scaling up.
    • 13 investors on this round.
  8. Series D+$309.0M2020-12-21
    • Raised 11 mo later, in step with the ~14 mo sector norm.
    • Round 3.4× larger than the prior — scaling up.
    • 21 investors on this round.
  9. Series D+$9.6M2021-03-17
    • Came back fast: 3 mo vs the ~14 mo sector norm.
    • Round 32.2× smaller than the prior — bridge or down round.
    • 65 investors on this round.
  10. Series D+$400.0M2021-10-22
    • Came back fast: 7 mo vs the ~14 mo sector norm.
    • Round 41.7× larger than the prior — scaling up.
    • 2 investors on this round.
Intelligence
2022 ~Q2
Modeled next raise · ~7mo cadence
$1.2B
Modeled next size est.range $780.0M$1.9B
41.7×
Last step-up
$156.8M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Teddie Wardi9 other2019-05
David Wood7 other2020-12
Peter Segall7 other2018-07
Ben Blume5 other2019-05
Steve Kraus5 other2020-01
Daniel Perez4 other2016-04
Elliott Robinson3 other2020-12
Jeffrey Krauss2 other2020-12
Gabriel Mecklenburg1 other2016-04
James Budge1 other2020-12
Ron Will1 other2021-03
Alexander Annison2020-12
Carolina Brochado2017-07
Jim Pursley2020-12
Lalith Vadlamannati2020-12
Mario Queiroz2020-12
Registry & provenance

Hinge Health, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1673743
SEC CIK
Recent activityActive

Discovered from hingehealth — the partnerships, launches, hiring and press it publishes about itself. Evidence the company is alive and what it is doing now, not financial data.

Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Lyra Health, Inc.HealthtechSeries D+$867.7M$4.3Bsame sector · same stage
Auris Health, Inc.HealthtechSeries D+$718.1M$5.3Bsame sector · same stage
Aledade, Inc.HealthtechSeries D+$662.6M$3.5Bsame sector · same stage
Imperative Care, Inc.HealthtechSeries D+$584.7M$713.0Msame sector · same stage
Monogram Health Holdings, Inc.HealthtechSeries D+$535.1M$5.5Bsame sector · same stage
Insightec LtdHealthtechSeries D+$436.4M$1.6Bsame sector · same stage
RefleXion Medical, Inc.HealthtechSeries D+$413.0M$1.3Bsame sector · same stage
Spring Care, Inc.HealthtechSeries D+$385.9M$1.0Bsame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
HealthPals, Inc.HealthtechSeed$52.7M77%
FirstHand Health, Inc.HealthtechSeries B$302.8M77%
Jawbone Health Hub, Inc.HealthtechSeries C$1.7B76%
Wheel Health, Inc.HealthtechSeries B$686.1M75%
ClinicaHealth, Inc.HealthtechSeries B$313.5M75%
Virtual Health Partners, Inc.HealthtechSeed$43.2M75%
Virtual Dental Care, Inc.HealthtechSeed$87.4M75%
HealthJay, Inc.HealthtechPre-Seed$15.6M75%
Frequently asked
How much funding has Hinge Health, Inc. raised?
Hinge Health, Inc. has raised approximately $862.5M in disclosed capital across 9 recorded financing rounds, aggregated from public filings.
What is Hinge Health, Inc.'s estimated valuation?
Provath's modeled valuation for Hinge Health, Inc. is approximately $7.7B (modeled range $2.1B–$14.5B). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Hinge Health, Inc. at?
Hinge Health, Inc.'s latest modeled financing stage is Series D+. Its most recent recorded round closed around Fri Oct 22.
What does Hinge Health, Inc. do and where is it based?
Hinge Health, Inc. operates in the Healthtech sector, based in SAN FRANCISCO. The #1 clinic for joint & muscle pain. Join today and take control of your pain with access to our personalized virtual physical therapy program
Explore related

See where Hinge Health, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Hinge Health, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.